DBT Antikörper

Produktnummer ABIN2719239

Produktdetails anti-DBT Antikörper

Target: DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser DBT Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS)

Produktmerkmale: Homo sapiens dihydrolipoamide branched chain transacylase E2 (DBT), nuclear gene encoding mitochondrial protein

Aufreinigung: Purified from mouse ascites fluids by affinity chromatography

Immunogen: Full length human recombinant protein of human DBT(NP_001909) produced in HEK293T cell.

Klon: 1G2

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: WB 1:2000, FLOW 1:100,

Kommentare:

The concentration of the product may vary between diferrent lots.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu DBT

Target: DBT (Dihydrolipoamide Branched Chain Transacylase E2 (DBT))

Andere Bezeichnung: DBT (DBT Produkte)

Substanzklasse: Viral Protein

Hintergrund: The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

Molekulargewicht: 46.4 kDa

Gen-ID: 1629

NCBI Accession: NM_001918

HGNC: 1629